 | • レポートコード：QYR2104Z2533 • 出版社/出版日：QYResearch / 2021年4月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ジェネリック医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シンプルジェネリック医薬品、スーパージェネリック医薬品、バイオシミラー）、用途別市場規模（中枢神経系、循環器、呼吸器、リウマチ、糖尿病、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ジェネリック医薬品の市場動向 ・企業の競争状況、市場シェア ・ジェネリック医薬品の種類別市場規模（シンプルジェネリック医薬品、スーパージェネリック医薬品、バイオシミラー） ・ジェネリック医薬品の用途別市場規模（中枢神経系、循環器、呼吸器、リウマチ、糖尿病、腫瘍、その他） ・ジェネリック医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・ジェネリック医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ジェネリック医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ジェネリック医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・ジェネリック医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva、Novartis - Sandoz、Mylan、Sun Pharmaceutical、Aspen、Fresenius Kabi、Pfizer (Hospira)、Sanofi、Aurobindo、Lupin、Dr. Reddy's、Apotex、Cipla、ENDO (Par Pharmaceutical)、Stada Arzneimittel、Krka Group、Nichi-Iko Pharmaceutical、Valeant、Zydus Cadila、Hikma） ・結論 |
Market Analysis and Insights: Global Generic Medicine Market
The global Generic Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Generic Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Generic Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Generic Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Generic Medicine market.
Global Generic Medicine Scope and Market Size
Generic Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Generic Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Simple Generic Drugs
Super Generic Drugs
Biosimilars
By Application:
CNS
Cardiovascular
Respiratory
Rheumatology
Diabetes
Oncology
Segment by Application
CNS
Cardiovascular
Respiratory
Rheumatology
Diabetes
Oncology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Teva
Novartis – Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy’s
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.2.5 By Application:
1.2.6 CNS
1.2.7 Cardiovascular
1.2.8 Respiratory
1.2.9 Rheumatology
1.2.10 Diabetes
1.2.11 Oncology
1.3 Market by Application
1.3.1 Global Generic Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Respiratory
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Medicine Market Perspective (2016-2027)
2.2 Generic Medicine Growth Trends by Regions
2.2.1 Generic Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Generic Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Generic Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Generic Medicine Industry Dynamic
2.3.1 Generic Medicine Market Trends
2.3.2 Generic Medicine Market Drivers
2.3.3 Generic Medicine Market Challenges
2.3.4 Generic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Medicine Players by Revenue
3.1.1 Global Top Generic Medicine Players by Revenue (2016-2021)
3.1.2 Global Generic Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Generic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Generic Medicine Revenue
3.4 Global Generic Medicine Market Concentration Ratio
3.4.1 Global Generic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Medicine Revenue in 2020
3.5 Generic Medicine Key Players Head office and Area Served
3.6 Key Players Generic Medicine Product Solution and Service
3.7 Date of Enter into Generic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Medicine Breakdown Data by Type
4.1 Global Generic Medicine Historic Market Size by Type (2016-2021)
4.2 Global Generic Medicine Forecasted Market Size by Type (2022-2027)
5 Generic Medicine Breakdown Data by Application
5.1 Global Generic Medicine Historic Market Size by Application (2016-2021)
5.2 Global Generic Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Generic Medicine Market Size (2016-2027)
6.2 North America Generic Medicine Market Size by Type
6.2.1 North America Generic Medicine Market Size by Type (2016-2021)
6.2.2 North America Generic Medicine Market Size by Type (2022-2027)
6.2.3 North America Generic Medicine Market Size by Type (2016-2027)
6.3 North America Generic Medicine Market Size by Application
6.3.1 North America Generic Medicine Market Size by Application (2016-2021)
6.3.2 North America Generic Medicine Market Size by Application (2022-2027)
6.3.3 North America Generic Medicine Market Size by Application (2016-2027)
6.4 North America Generic Medicine Market Size by Country
6.4.1 North America Generic Medicine Market Size by Country (2016-2021)
6.4.2 North America Generic Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Generic Medicine Market Size (2016-2027)
7.2 Europe Generic Medicine Market Size by Type
7.2.1 Europe Generic Medicine Market Size by Type (2016-2021)
7.2.2 Europe Generic Medicine Market Size by Type (2022-2027)
7.2.3 Europe Generic Medicine Market Size by Type (2016-2027)
7.3 Europe Generic Medicine Market Size by Application
7.3.1 Europe Generic Medicine Market Size by Application (2016-2021)
7.3.2 Europe Generic Medicine Market Size by Application (2022-2027)
7.3.3 Europe Generic Medicine Market Size by Application (2016-2027)
7.4 Europe Generic Medicine Market Size by Country
7.4.1 Europe Generic Medicine Market Size by Country (2016-2021)
7.4.2 Europe Generic Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Generic Medicine Market Size (2016-2027)
8.2 Asia-Pacific Generic Medicine Market Size by Type
8.2.1 Asia-Pacific Generic Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Generic Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Generic Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Generic Medicine Market Size by Application
8.3.1 Asia-Pacific Generic Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Generic Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Generic Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Generic Medicine Market Size by Region
8.4.1 Asia-Pacific Generic Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Generic Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Generic Medicine Market Size (2016-2027)
9.2 Latin America Generic Medicine Market Size by Type
9.2.1 Latin America Generic Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Generic Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Generic Medicine Market Size by Type (2016-2027)
9.3 Latin America Generic Medicine Market Size by Application
9.3.1 Latin America Generic Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Generic Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Generic Medicine Market Size by Application (2016-2027)
9.4 Latin America Generic Medicine Market Size by Country
9.4.1 Latin America Generic Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Generic Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Medicine Market Size (2016-2027)
10.2 Middle East & Africa Generic Medicine Market Size by Type
10.2.1 Middle East & Africa Generic Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Generic Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Generic Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Generic Medicine Market Size by Application
10.3.1 Middle East & Africa Generic Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Generic Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Generic Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Generic Medicine Market Size by Country
10.4.1 Middle East & Africa Generic Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Generic Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Generic Medicine Introduction
11.1.4 Teva Revenue in Generic Medicine Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Novartis – Sandoz
11.2.1 Novartis – Sandoz Company Details
11.2.2 Novartis – Sandoz Business Overview
11.2.3 Novartis – Sandoz Generic Medicine Introduction
11.2.4 Novartis – Sandoz Revenue in Generic Medicine Business (2016-2021)
11.2.5 Novartis – Sandoz Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Generic Medicine Introduction
11.3.4 Mylan Revenue in Generic Medicine Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Medicine Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Medicine Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Aspen
11.5.1 Aspen Company Details
11.5.2 Aspen Business Overview
11.5.3 Aspen Generic Medicine Introduction
11.5.4 Aspen Revenue in Generic Medicine Business (2016-2021)
11.5.5 Aspen Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Medicine Introduction
11.6.4 Fresenius Kabi Revenue in Generic Medicine Business (2016-2021)
11.6.5 Fresenius Kabi Recent Development
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Details
11.7.2 Pfizer (Hospira) Business Overview
11.7.3 Pfizer (Hospira) Generic Medicine Introduction
11.7.4 Pfizer (Hospira) Revenue in Generic Medicine Business (2016-2021)
11.7.5 Pfizer (Hospira) Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Generic Medicine Introduction
11.8.4 Sanofi Revenue in Generic Medicine Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Aurobindo
11.9.1 Aurobindo Company Details
11.9.2 Aurobindo Business Overview
11.9.3 Aurobindo Generic Medicine Introduction
11.9.4 Aurobindo Revenue in Generic Medicine Business (2016-2021)
11.9.5 Aurobindo Recent Development
11.10 Lupin
11.10.1 Lupin Company Details
11.10.2 Lupin Business Overview
11.10.3 Lupin Generic Medicine Introduction
11.10.4 Lupin Revenue in Generic Medicine Business (2016-2021)
11.10.5 Lupin Recent Development
11.11 Dr. Reddy’s
11.11.1 Dr. Reddy’s Company Details
11.11.2 Dr. Reddy’s Business Overview
11.11.3 Dr. Reddy’s Generic Medicine Introduction
11.11.4 Dr. Reddy’s Revenue in Generic Medicine Business (2016-2021)
11.11.5 Dr. Reddy’s Recent Development
11.12 Apotex
11.12.1 Apotex Company Details
11.12.2 Apotex Business Overview
11.12.3 Apotex Generic Medicine Introduction
11.12.4 Apotex Revenue in Generic Medicine Business (2016-2021)
11.12.5 Apotex Recent Development
11.13 Cipla
11.13.1 Cipla Company Details
11.13.2 Cipla Business Overview
11.13.3 Cipla Generic Medicine Introduction
11.13.4 Cipla Revenue in Generic Medicine Business (2016-2021)
11.13.5 Cipla Recent Development
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Details
11.14.2 ENDO (Par Pharmaceutical) Business Overview
11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Introduction
11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2016-2021)
11.14.5 ENDO (Par Pharmaceutical) Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Generic Medicine Introduction
11.15.4 Stada Arzneimittel Revenue in Generic Medicine Business (2016-2021)
11.15.5 Stada Arzneimittel Recent Development
11.16 Krka Group
11.16.1 Krka Group Company Details
11.16.2 Krka Group Business Overview
11.16.3 Krka Group Generic Medicine Introduction
11.16.4 Krka Group Revenue in Generic Medicine Business (2016-2021)
11.16.5 Krka Group Recent Development
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Details
11.17.2 Nichi-Iko Pharmaceutical Business Overview
11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Introduction
11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2016-2021)
11.17.5 Nichi-Iko Pharmaceutical Recent Development
11.18 Valeant
11.18.1 Valeant Company Details
11.18.2 Valeant Business Overview
11.18.3 Valeant Generic Medicine Introduction
11.18.4 Valeant Revenue in Generic Medicine Business (2016-2021)
11.18.5 Valeant Recent Development
11.18 Zydus Cadila
.1 Zydus Cadila Company Details
.2 Zydus Cadila Business Overview
.3 Zydus Cadila Generic Medicine Introduction
.4 Zydus Cadila Revenue in Generic Medicine Business (2016-2021)
.5 Zydus Cadila Recent Development
11.20 Hikma
11.20.1 Hikma Company Details
11.20.2 Hikma Business Overview
11.20.3 Hikma Generic Medicine Introduction
11.20.4 Hikma Revenue in Generic Medicine Business (2016-2021)
11.20.5 Hikma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Generic Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Simple Generic Drugs
Table 3. Key Players of Super Generic Drugs
Table 4. Key Players of Biosimilars
Table 5. Key Players of By Application:
Table 6. Key Players of CNS
Table 7. Key Players of Cardiovascular
Table 8. Key Players of Respiratory
Table 9. Key Players of Rheumatology
Table 10. Key Players of Diabetes
Table 11. Key Players of Oncology
Table 12. Global Generic Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Generic Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Generic Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Generic Medicine Market Share by Regions (2016-2021)
Table 16. Global Generic Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Generic Medicine Market Share by Regions (2022-2027)
Table 18. Generic Medicine Market Trends
Table 19. Generic Medicine Market Drivers
Table 20. Generic Medicine Market Challenges
Table 21. Generic Medicine Market Restraints
Table 22. Global Generic Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Generic Medicine Market Share by Players (2016-2021)
Table 24. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Medicine as of 2020)
Table 25. Ranking of Global Top Generic Medicine Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Generic Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Generic Medicine Product Solution and Service
Table 29. Date of Enter into Generic Medicine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Generic Medicine Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Generic Medicine Revenue Market Share by Type (2016-2021)
Table 33. Global Generic Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Generic Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Generic Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Generic Medicine Revenue Market Share by Application (2016-2021)
Table 37. Global Generic Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Generic Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Generic Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Generic Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Generic Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Generic Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Generic Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Generic Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Generic Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Generic Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Generic Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Generic Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Generic Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Generic Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Generic Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Generic Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Generic Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Generic Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Generic Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Generic Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Generic Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Generic Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Generic Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Generic Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Generic Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Generic Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Generic Medicine Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Generic Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Generic Medicine Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Generic Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Generic Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Generic Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 69. Teva Company Details
Table 70. Teva Business Overview
Table 71. Teva Generic Medicine Product
Table 72. Teva Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 73. Teva Recent Development
Table 74. Novartis - Sandoz Company Details
Table 75. Novartis - Sandoz Business Overview
Table 76. Novartis - Sandoz Generic Medicine Product
Table 77. Novartis - Sandoz Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 78. Novartis - Sandoz Recent Development
Table 79. Mylan Company Details
Table 80. Mylan Business Overview
Table 81. Mylan Generic Medicine Product
Table 82. Mylan Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 83. Mylan Recent Development
Table 84. Sun Pharmaceutical Company Details
Table 85. Sun Pharmaceutical Business Overview
Table 86. Sun Pharmaceutical Generic Medicine Product
Table 87. Sun Pharmaceutical Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 88. Sun Pharmaceutical Recent Development
Table 89. Aspen Company Details
Table 90. Aspen Business Overview
Table 91. Aspen Generic Medicine Product
Table 92. Aspen Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 93. Aspen Recent Development
Table 94. Fresenius Kabi Company Details
Table 95. Fresenius Kabi Business Overview
Table 96. Fresenius Kabi Generic Medicine Product
Table 97. Fresenius Kabi Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 98. Fresenius Kabi Recent Development
Table 99. Pfizer (Hospira) Company Details
Table 100. Pfizer (Hospira) Business Overview
Table 101. Pfizer (Hospira) Generic Medicine Product
Table 102. Pfizer (Hospira) Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 103. Pfizer (Hospira) Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Aurobindo Company Details
Table 109. Aurobindo Business Overview
Table 110. Aurobindo Generic Medicine Product
Table 111. Aurobindo Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 112. Aurobindo Recent Development
Table 113. Lupin Company Details
Table 114. Lupin Business Overview
Table 115. Lupin Generic Medicine Product
Table 116. Lupin Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 117. Lupin Recent Development
Table 118. Dr. Reddy's Company Details
Table 119. Dr. Reddy's Business Overview
Table 120. Dr. Reddy's Generic Medicine Product
Table 121. Dr. Reddy's Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 122. Dr. Reddy's Recent Development
Table 123. Apotex Company Details
Table 124. Apotex Business Overview
Table 125. Apotex Generic Medicine Product
Table 126. Apotex Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 127. Apotex Recent Development
Table 128. Cipla Company Details
Table 129. Cipla Business Overview
Table 130. Cipla Generic Medicine Product
Table 131. Cipla Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 132. Cipla Recent Development
Table 133. ENDO (Par Pharmaceutical) Company Details
Table 134. ENDO (Par Pharmaceutical) Business Overview
Table 135. ENDO (Par Pharmaceutical) Generic Medicine Product
Table 136. ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 137. ENDO (Par Pharmaceutical) Recent Development
Table 138. Stada Arzneimittel Company Details
Table 139. Stada Arzneimittel Business Overview
Table 140. Stada Arzneimittel Generic Medicine Product
Table 141. Stada Arzneimittel Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 142. Stada Arzneimittel Recent Development
Table 143. Krka Group Company Details
Table 144. Krka Group Business Overview
Table 145. Krka Group Generic Medicine Product
Table 146. Krka Group Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 147. Krka Group Recent Development
Table 148. Nichi-Iko Pharmaceutical Company Details
Table 149. Nichi-Iko Pharmaceutical Business Overview
Table 150. Nichi-Iko Pharmaceutical Generic Medicine Product
Table 151. Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 152. Nichi-Iko Pharmaceutical Recent Development
Table 153. Valeant Company Details
Table 154. Valeant Business Overview
Table 155. Valeant Generic Medicine Product
Table 156. Valeant Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 157. Valeant Recent Development
Table 158. Zydus Cadila Company Details
Table 159. Zydus Cadila Business Overview
Table 160. Zydus Cadila Generic Medicine Product
Table 161. Zydus Cadila Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 162. Zydus Cadila Recent Development
Table 163. Hikma Company Details
Table 164. Hikma Business Overview
Table 165. Hikma Generic Medicine Product
Table 166. Hikma Revenue in Generic Medicine Business (2016-2021) & (US$ Million)
Table 167. Hikma Recent Development
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Medicine Market Share by Type: 2020 VS 2027
Figure 2. Simple Generic Drugs Features
Figure 3. Super Generic Drugs Features
Figure 4. Biosimilars Features
Figure 5. By Application: Features
Figure 6. CNS Features
Figure 7. Cardiovascular Features
Figure 8. Respiratory Features
Figure 9. Rheumatology Features
Figure 10. Diabetes Features
Figure 11. Oncology Features
Figure 12. Global Generic Medicine Market Share by Application: 2020 VS 2027
Figure 13. CNS Case Studies
Figure 14. Cardiovascular Case Studies
Figure 15. Respiratory Case Studies
Figure 16. Rheumatology Case Studies
Figure 17. Diabetes Case Studies
Figure 18. Oncology Case Studies
Figure 19. Others Case Studies
Figure 20. Generic Medicine Report Years Considered
Figure 21. Global Generic Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 22. Global Generic Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 23. Global Generic Medicine Market Share by Regions: 2020 VS 2027
Figure 24. Global Generic Medicine Market Share by Regions (2022-2027)
Figure 25. Global Generic Medicine Market Share by Players in 2020
Figure 26. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Medicine as of 2020
Figure 27. The Top 10 and 5 Players Market Share by Generic Medicine Revenue in 2020
Figure 28. Global Generic Medicine Revenue Market Share by Type (2016-2021)
Figure 29. Global Generic Medicine Revenue Market Share by Type (2022-2027)
Figure 30. North America Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. North America Generic Medicine Market Share by Type (2016-2027)
Figure 32. North America Generic Medicine Market Share by Application (2016-2027)
Figure 33. North America Generic Medicine Market Share by Country (2016-2027)
Figure 34. United States Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Canada Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Europe Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Europe Generic Medicine Market Share by Type (2016-2027)
Figure 38. Europe Generic Medicine Market Share by Application (2016-2027)
Figure 39. Europe Generic Medicine Market Share by Country (2016-2027)
Figure 40. Germany Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. France Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. U.K. Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Italy Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Russia Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Nordic Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Asia-Pacific Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Asia-Pacific Generic Medicine Market Share by Type (2016-2027)
Figure 48. Asia-Pacific Generic Medicine Market Share by Application (2016-2027)
Figure 49. Asia-Pacific Generic Medicine Market Share by Region (2016-2027)
Figure 50. China Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Japan Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. South Korea Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Southeast Asia Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. India Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Australia Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Latin America Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Latin America Generic Medicine Market Share by Type (2016-2027)
Figure 58. Latin America Generic Medicine Market Share by Application (2016-2027)
Figure 59. Latin America Generic Medicine Market Share by Country (2016-2027)
Figure 60. Mexico Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Brazil Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Middle East & Africa Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Middle East & Africa Generic Medicine Market Share by Type (2016-2027)
Figure 64. Middle East & Africa Generic Medicine Market Share by Application (2016-2027)
Figure 65. Middle East & Africa Generic Medicine Market Share by Country (2016-2027)
Figure 66. Turkey Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 67. Saudi Arabia Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 68. UAE Generic Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 69. Teva Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 70. Novartis - Sandoz Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 71. Mylan Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 72. Sun Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 73. Aspen Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 74. Fresenius Kabi Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 75. Pfizer (Hospira) Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 76. Sanofi Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 77. Aurobindo Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 78. Lupin Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 79. Dr. Reddy's Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 80. Apotex Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 81. Cipla Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 82. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 83. Stada Arzneimittel Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 84. Krka Group Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 85. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 86. Valeant Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 87. Zydus Cadila Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 88. Hikma Revenue Growth Rate in Generic Medicine Business (2016-2021)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed